Clinical Trial: A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06866405) titled 'A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose' on March 04.

Brief Summary: This study aims to check how safe and well-tolerated a second dose of RSVpreF is when given during later pregnancies, and to see how long the immunity lasts from a single dose given during a previous pregnancy by examining the blood of nonpregnant participants who had the vaccine before.

Study Start Date: April 08

Study Type: INTERVENTIONAL

Condition: RSV Infection

Intervention: BIOLOGICAL: RSVpreF

Single Dose

BIOLOGICAL: Placebo

Single Dose

Recruitment Status: NOT_Y...